Ninety One SA PTY Ltd decreased its stake in shares of Zoetis Inc. (NYSE:ZTS - Free Report) by 49.2% during the 1st quarter, according to its most recent Form 13F filing with the SEC. The fund owned 1,855 shares of the company's stock after selling 1,800 shares during the period. Ninety One SA PTY Ltd's holdings in Zoetis were worth $302,000 as of its most recent filing with the SEC.
Several other large investors have also modified their holdings of ZTS. Rakuten Securities Inc. raised its holdings in shares of Zoetis by 5,533.3% during the fourth quarter. Rakuten Securities Inc. now owns 169 shares of the company's stock valued at $28,000 after buying an additional 166 shares during the last quarter. Navigoe LLC acquired a new position in shares of Zoetis during the fourth quarter valued at approximately $30,000. Murphy & Mullick Capital Management Corp acquired a new position in shares of Zoetis during the fourth quarter valued at approximately $44,000. Sound Income Strategies LLC increased its stake in shares of Zoetis by 141.4% during the first quarter. Sound Income Strategies LLC now owns 280 shares of the company's stock valued at $46,000 after acquiring an additional 164 shares during the period. Finally, Bfsg LLC increased its stake in shares of Zoetis by 614.6% during the first quarter. Bfsg LLC now owns 293 shares of the company's stock valued at $48,000 after acquiring an additional 252 shares during the period. Institutional investors own 92.80% of the company's stock.
Analysts Set New Price Targets
A number of research firms recently commented on ZTS. Stifel Nicolaus lowered shares of Zoetis from a "buy" rating to a "hold" rating and lowered their price objective for the company from $165.00 to $160.00 in a research note on Wednesday, June 18th. Piper Sandler lifted their price target on shares of Zoetis from $205.00 to $210.00 and gave the stock an "overweight" rating in a research report on Monday, May 12th. Finally, UBS Group decreased their price target on shares of Zoetis from $189.00 to $170.00 and set a "neutral" rating on the stock in a research report on Wednesday, May 7th. Two equities research analysts have rated the stock with a hold rating, seven have given a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of "Buy" and a consensus target price of $212.13.
View Our Latest Stock Report on ZTS
Insider Buying and Selling
In related news, EVP Roxanne Lagano sold 652 shares of Zoetis stock in a transaction on Tuesday, June 3rd. The shares were sold at an average price of $170.00, for a total value of $110,840.00. Following the transaction, the executive vice president owned 15,129 shares in the company, valued at $2,571,930. This trade represents a 4.13% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. 0.16% of the stock is owned by company insiders.
Zoetis Stock Down 0.9%
Shares of NYSE:ZTS traded down $1.37 during trading on Wednesday, reaching $156.43. 703,532 shares of the company traded hands, compared to its average volume of 2,571,605. The company has a quick ratio of 1.04, a current ratio of 1.74 and a debt-to-equity ratio of 1.12. Zoetis Inc. has a 1-year low of $139.70 and a 1-year high of $200.33. The firm has a fifty day simple moving average of $161.27 and a 200 day simple moving average of $161.99. The firm has a market cap of $69.64 billion, a P/E ratio of 28.17, a price-to-earnings-growth ratio of 2.60 and a beta of 0.91.
Zoetis (NYSE:ZTS - Get Free Report) last released its quarterly earnings data on Tuesday, May 6th. The company reported $1.48 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.40 by $0.08. Zoetis had a net margin of 27.12% and a return on equity of 55.48%. The business had revenue of $2.22 billion during the quarter, compared to analyst estimates of $2.20 billion. During the same quarter in the previous year, the business earned $1.38 EPS. Zoetis's quarterly revenue was up 1.4% compared to the same quarter last year. Analysts anticipate that Zoetis Inc. will post 6.07 earnings per share for the current fiscal year.
Zoetis Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Wednesday, September 3rd. Investors of record on Friday, July 18th will be issued a $0.50 dividend. The ex-dividend date is Friday, July 18th. This represents a $2.00 annualized dividend and a yield of 1.28%. Zoetis's dividend payout ratio (DPR) is presently 35.91%.
About Zoetis
(
Free Report)
Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.
Further Reading
Before you consider Zoetis, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Zoetis wasn't on the list.
While Zoetis currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
